Click Therapeutics' digital therapeutic (DTx) CT-132 has been approved by the FDA, becoming the first treatment of its type in the US for preventing attacks in people with episodic migraine.

I’ve been writing about technology since 2012, focusing on privacy. With companies vying for user data, AI skimming it for tools, and countless bad actors seeking to exploit it, safeguarding the ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...